A randomized, double-blind, placebo-controlled, multicenter study that assessed the endometrial effects of norethindrone acetate plus ethinyl estradiol versus ethinyl estradiol alone.

Author: KempfertNona J, PortmanDavid J, SymonsJames P, WilbornWalter

Paper Details 
Original Abstract of the Article :
OBJECTIVE: The purpose of this study was to determine the incidence of endometrial hyperplasia in subjects who receive continuous norethindrone acetate and ethinyl estradiol combinations versus unopposed ethinyl estradiol. STUDY DESIGN: Nine hundred forty-five postmenopausal women were randomly sel...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1067/mob.2003.91

データ提供:米国国立医学図書館(NLM)

Protecting the Endometrium: Investigating the Effects of Hormone Therapy

Hormone therapy is a complex topic, with ongoing research focused on understanding its long-term effects. This study delves into the endometrial effects of different hormone combinations, specifically norethindrone acetate and ethinyl estradiol, in postmenopausal women. Researchers compared the incidence of endometrial hyperplasia in women receiving continuous combined therapy versus those receiving unopposed ethinyl estradiol. The study's findings shed light on the protective role of norethindrone acetate in preventing estrogen-induced endometrial hyperplasia and highlight the importance of careful consideration of hormone therapy regimens in postmenopausal women.

Norethindrone Acetate: A Shield for the Endometrium

The study demonstrates the protective effects of norethindrone acetate on the endometrium. The researchers found that norethindrone acetate significantly reduced the incidence of endometrial hyperplasia and proliferation, suggesting a beneficial role in protecting the endometrium from estrogen-induced changes.

Balancing Hormones: Weighing the Benefits and Risks

This study underscores the importance of personalized hormone therapy, tailored to the individual needs and risks of each patient. The research highlights the potential benefits of norethindrone acetate in protecting the endometrium, but it's crucial to discuss the potential risks and benefits of hormone therapy with your healthcare provider.

Dr.Camel's Conclusion

This study provides valuable insights into the endometrial effects of hormone therapy, showcasing the potential protective role of norethindrone acetate in reducing the risk of estrogen-induced hyperplasia.

Date :
  1. Date Completed 2003-03-27
  2. Date Revised 2019-06-16
Further Info :

Pubmed ID

12592236

DOI: Digital Object Identifier

10.1067/mob.2003.91

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.